Skip to main content
Integrity IndexIntegrity Index
← Companies
MIRM

Mirum Pharmaceuticals, Inc.

Data as of Oct 16, 2026
MIRM
CIK 1759425Pharmaceutical Preparations
Reported federal lobbying
$0
1 filings · latest Sep 4, 2026
Federal contracts since 2024
$458K
2 awards · latest Jun 13, 2025

Lobbying

$0 in reported federal lobbying spend across 1 quarterly filings, most recently Sep 4, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.

Latest filings, Sep 2026 onward

FiledRegistrant and subjectAmount
Sep 4, 2026
LMH STRATEGIC SOLUTIONS for MIRUM PHARMACEUTICALS INC.
Health Issues FDA issues.
$0

Data: FEC (PAC contributions, Schedule A), Quiver Quantitative (congressional holdings, lobbying, contracts), Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to Mirum Pharmaceuticals, Inc. through its SEC registration (CIK 1759425) and tickers MIRM.

As of: lobbying filings through Sep 4, 2026; contract actions through Jun 13, 2025. Snapshot rebuilt Oct 16, 2026.

Holdings values are estimates from disclosed ranges. PAC contributions cover the current and previous election cycle and count only gifts to sitting members' principal campaign committees, so leadership PACs and losing candidates are not included.